Literature DB >> 3072485

Relaxant effect of dopamine on the isolated rat uterus.

L Estañ1, I Martinez-Mir, E Rubio, F J Morales-Olivas.   

Abstract

The effect of dopamine was studied on the isolated uterus of diethylstilboestrol-treated rats. Dopamine, at concentrations (10(7)-10(-4) M) produced a concentration-dependent relaxation in the K+-depolarized rat uterus. On a molar basis, dopamine was about 500 times less potent than adrenaline in relaxing the uterus, the maximum degree of relaxation obtained with both drugs was the same. Pretreatment of the rats with reserpine (5 mg/kg) did not produce any modification of the dose-response curve to dopamine. Similarly, cocaine (3 x 10(-6) M) failed to modify the relaxant effect of dopamine. The dopamine induced relaxation was inhibited by propranolol (10(-9)-10(-7) M) in a dose-dependent manner. Prazosin (10(-7) M), SCH 23390 (10(-7) M) and sulpiride (10(-7) M) did not affect the dopamine dose-response curve. In the isolated rat uterus which was not preconstricted by KCl neither dopamine nor adrenaline produced any effect when added to the organ bath. This lack of response to both catecholamines was present even in tissues pretreated with propranolol or sulpiride. It is concluded that dopamine produced a concentration-dependent relaxation of the uterus from diethylstilboestrol-treated rats by direct activation of beta-adrenoceptors. There was no evidence for indirect action (catecholamine release and neuronal uptake mechanisms) and specific dopamine receptor mediated relaxation and alpha-adrenoceptor mediated contractions have not been found in this preparation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3072485     DOI: 10.1007/bf00179318

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

1.  SCH 23390 is a very potent and selective antagonist at vascular dopamine receptors.

Authors:  A Hilditch; G M Drew; R J Naylor
Journal:  Eur J Pharmacol       Date:  1984-01-27       Impact factor: 4.432

2.  Indirect sympathomimetic effect of some H2-histamine receptor antagonists in the isolated uterus of the rat.

Authors:  E Rubio; F J Morales-Olivas; E Morcillo; J Esplugues
Journal:  J Pharm Pharmacol       Date:  1982-11       Impact factor: 3.765

3.  The lack of the effect of DA-1 and DA-2 dopamine agonists on the isolated guinea-pig atria.

Authors:  I Martinez-Mir; F J Morales-Olivas; E Rubio
Journal:  J Auton Pharmacol       Date:  1987-06

4.  Stimulation by adrenaline and dopamine but not by noradrenaline of myocardial alpha-adrenoceptors mediating positive inotropic effects in human atrial preparations.

Authors:  J Wagner; H J Schümann; A Knorr; N Rohm; J C Reidemeister
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

5.  Studies on the positive inotropic effect of dopamine in the guinea-pig heart.

Authors:  A Mugelli; F Ledda; L Mantelli; M Torrini; T Maccioni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-12       Impact factor: 3.000

6.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

7.  Pharmacological investigation into the effects of histamine and histamine analogues on guinea-pig and rat colon in vitro.

Authors:  M J Aguilar; F J Morales-Olivas; E Rubio
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

8.  Dopamine receptors and dopaminergic nerves in the vas deferens of the rat.

Authors:  A Simon; E F Van Maanen
Journal:  Arch Int Pharmacodyn Ther       Date:  1976-07

9.  Effect of methoxamine on spontaneous motility of the isolated rat uterus.

Authors:  L Estañ; F J Morales-Olivas; E Rubio; J Esplugues
Journal:  Gynecol Obstet Invest       Date:  1985       Impact factor: 2.031

10.  Responses to catecholamines of the rat isolated uterus throughout the natural oestrous cycle.

Authors:  F C Boyle; K G Digges
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.